S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

LXEO Lexeo Therapeutics Inc

11.98

0.48 (4.17%)

After Hours

Last Updated: 06:27:47

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Lexeo Therapeutics (NASDAQ:LXEO)
Historical Stock Chart
From Jul 2024 to Aug 2024

Click Here for more Lexeo Therapeutics Charts.

Lexeo Therapeutics (NASDAQ:LXEO)
Historical Stock Chart
From Aug 2023 to Aug 2024

Click Here for more Lexeo Therapeutics Charts.

Lexeo Therapeutics Inc News

Form 424B3 - Prospectus [Rule 424(b)(3)]
Monday 12 August 2024 (12 hours ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 12 August 2024 (12 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 12 August 2024 (13 hours ago) • Edgar (US Regulatory)

Lexeo Therapeutics Reports Second Quarter 2024 Financial Results and Operational Highlights
Monday 12 August 2024 (13 hours ago) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Monday 15 July 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 15 July 2024 (4 weeks ago) • Edgar (US Regulatory)

Lexeo Therapeutics Announces Positive Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
Monday 15 July 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 13 July 2024 (1 month ago) • Edgar (US Regulatory)

Lexeo Therapeutics Announces Investor Webcast to Report Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy on Monday, July 15, 2024
Thursday 11 July 2024 (1 month ago) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Monday 8 July 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 8 July 2024 (1 month ago) • Edgar (US Regulatory)

Lexeo Therapeutics Appoints Tim Van Hauwermeiren to its Board of Directors
Monday 8 July 2024 (1 month ago) • GlobeNewswire Inc.

More Lexeo Therapeutics Inc News Articles

S&P ASX 300 Metals and M...

Gold vs US Dollar

AUD vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions